AnewCRO is Bioculture Group’s U.S.-based preclinical contract research organization, delivering NHP-focused pharmacology, toxicology, and neuroscience services. Combining scientific expertise with ethical standards, AnewCRO provides translational research solutions that bridge discovery to regulatory readiness.
About AnewCRO
Founded in 1984 by conservationists Mary-Ann and Owen Griffiths
Company History
Headquartered in Florida, AnewCRO operates as a state-of-the-art preclinical research facility specializing in non-human primate (NHP) studies.
Its mission is to elevate the standards of preclinical science through ethical innovation, technical precision, and transparent collaboration.
Role within the Bioculture Group
As a core component of Bioculture’s Care to Cure model, AnewCRO integrates seamlessly with Franklin Biolabs and Bioculture Mauritius — linking ethical NHP sourcing, advanced laboratory research, and regulatory-compliant study execution.
This vertical integration ensures consistent quality, traceability, and welfare from source to study.
U.S. Market Focus
- Fully integrated NHP research platform within an AAALAC-accredited facility.
- Expertise in IND-enabling pharmacology, toxicology, and behavioral neuroscience.
- Modern vivarium infrastructure designed for welfare and scientific accuracy.
- Multi-disciplinary teams combining CRO management and academic research experience.
Our Services
Core CRO Services
AnewCRO provides comprehensive preclinical research services tailored to the needs of pharmaceutical, biotechnology, and medical research clients.
Preclinical Toxicology Studies
Drug efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) assessments in NHP models.
Toxicology Programs
GLP and non-GLP studies for safety evaluation and dose-range finding.
Behavioral and Neuroscience Research
Cognitive and sensory studies leveraging advanced neuro-assessment tools.
Ocular and CNS Models
Preclinical programs supporting gene therapy, ophthalmology, and neurology therapeutics.
Immunology & Vaccine Development
NHP studies evaluating immune response and vaccine safety.
Clinical Trial Management Support
Preclinical-to-clinical transition consulting.
- Differentiators:
- Purpose-built NHP preclinical facility designed to exceed global welfare and biosafety standards.
- Experienced team with cross-industry backgrounds in CRO, academia, and biopharma R&D.
- Seamless integration with Bioculture’s ethical breeding and research network.
- Accelerated study timelines supported by in-house logistics and regulatory teams.
- Origin: Mauritius — SPF breeding and health certification.
- Transit Hub: Florida, USA (BCUS LLC) — quarantine and acclimation.
- Destination Markets: United States, Europe, and selected research partners in Asia.
- IATA-compliant animal transport.
- Dedicated welfare-trained logistics staff.
- End-to-end digital tracking for traceability.
Therapeutic Areas
AnewCRO’s expertise spans multiple therapeutic domains, providing translational data that accelerate the development of life-saving therapies.
Areas of Specialization
- Gene & Cell Therapy
- Vaccines and Immunology
- Neurology and CNS Disorders
- Ophthalmology
- Oncology and Metabolic Disease
- Infectious and Emerging Diseases
Disease Focus
- Neurodegenerative disorders (Alzheimer’s, Parkinson’s)
- Ocular diseases (Retinal degeneration, glaucoma)
- Genetic and metabolic syndromes
- Viral infections and immune disorders
Technology
& Innovation
AnewCRO integrates modern technology platforms to enhance scientific accuracy, data reliability, and animal welfare.
Platforms Used
- High-precision telemetry and behavioral tracking systems.
- Automated dosing and sampling technologies.
- AI-supported imaging for ocular and CNS endpoints.
- Molecular assay systems for biomarker and immunology research.
Platforms Used
- High-precision telemetry and behavioral tracking systems.
- Automated dosing and sampling technologies.
- AI-supported imaging for ocular and CNS endpoints.
- Molecular assay systems for biomarker and immunology research.
Platforms Used
- High-precision telemetry and behavioral tracking systems.
- Automated dosing and sampling technologies.
- AI-supported imaging for ocular and CNS endpoints.
- Molecular assay systems for biomarker and immunology research.
Contact Bioculture (Mauritius) Ltd
For NHP supply inquiries, compliance documentation, or partnership discussions, please contact our Mauritius office directly.
- +230 217 2735
- www.bioculturegroup.com
- Pailles, Mauritius
- info@bioculturegroup.com
